BfArM Guideline for the Application for a Licence to Cultivate Cannabis
Recommendation

Thursday, 29 October 2026 9 .00 - 17.15 h
AI/ML-based Methods for Optimizing Pharmaceutical Research Processes
The German Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte - BfArM) has published guidelines on applying for a licence to cultivate cannabis for medicinal purposes in accordance with Section 4 of the German Medicinal Cannabis Act (MedCanG).
The guideline provides details on the information and documents that must be included with the application for a licence to cultivate cannabis. In addition to a cover letter, a variety of other information must be included, such as
- Proof of the expertise of each responsible person in accordance with Section 7 (3) MedCanG,
- A description of the cultivation and production process,
- Information on germ reduction measures,
- Confirmation of compliance with GACP guidelines (Good agricultural and collection practice)
- A valid manufacturing authorisation / GMP certificate of the competent authority for the production steps (e.g. drying or further steps if necessary) of medicinal cannabis flowers associated with the cultivation.
More information is available on the BfArM website in the guideline "Leitfaden zum Antrag auf Erteilung einer Erlaubnis nach § 4 Medizinal-Cannabisgesetz (MedCanG) zum Anbau von Cannabis zu medizinischen Zwecken".
Related GMP News
29.09.2026FDA wants to Advance the Development of Herbal Medicinal Products
29.09.2026Ph. Eur. Draft for Comment: 2.8.18. Determination of Aflatoxin B1 in Herbal Drugs
29.09.2026Can Cannabis Flowers be pre-dried in Accordance with GACP?
29.09.2026Water Determination in Herbal Drugs
10.09.2026New Information Sheet regarding Cannabis for Medical Purposes
10.09.2026EMA Reflection Paper on Safety Signals for Herbal Medicinal Products


